Literature DB >> 3005648

Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

W J Britt, D Auger.   

Abstract

The envelope of human cytomegalovirus has been reported to contain between three and eight glycoproteins. Major constituents of the envelope include two abundant glycoproteins with estimated molecular weights of 55,000 (gp55) and 116,000 (gp116). These two glycoproteins have been shown to exist as a disulfide-linked complex (gp55-116) within the envelope of mature virions. Utilizing a panel of monoclonal antibodies reactive with the gp55-116 complex, we characterized the synthesis and processing of these two virion proteins. Infected cells were shown to contain two glycosylated proteins of 160,000 and 150,000 daltons as well as the mature gp55 and gp116. Pulse-chase analysis indicated that gp150 was a precursor protein of gp160. The mature gp55 and gp116 were generated, in turn, by cleavage of gp160. Antigenic and structural analysis revealed that gp55 and gp116 shared little structural homology and no detectable antigenic cross-reactivity. The results of this study are discussed in relation to the synthesis of envelope proteins of other herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005648      PMCID: PMC252892     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Extracellular cleavage of the glycoprotein precursor of Rous sarcoma virus.

Authors:  R Klemenz; H Diggelmann
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

2.  The nature of the association between the murine leukemia virus envelope proteins.

Authors:  A Pinter; J Lieman-Hurwitz; E Fleissner
Journal:  Virology       Date:  1978-12       Impact factor: 3.616

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Complement-fixing and virus-neutralizing antibodies in cytomegalovirus infection as measured against homologous and heterologous antigen.

Authors:  H K Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

5.  Characterization of the human cytomegalovirus envelope glycoproteins.

Authors:  G H Farrar; J D Oram
Journal:  J Gen Virol       Date:  1984-11       Impact factor: 3.891

6.  HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.

Authors:  G V Quinnan; N Kirmani; E Esber; R Saral; J F Manischewitz; J L Rogers; A H Rook; G W Santos; W H Burns
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

Review 7.  Synthesis and processing of asparagine-linked oligosaccharides.

Authors:  S C Hubbard; R J Ivatt
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Human cytomegalovirus: glycoproteins associated with virions and dense bodies.

Authors:  M F Stinski
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

9.  Analysis of structural polypeptides of purified human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; R I Carp; H M Moon
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

10.  Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies.

Authors:  M Fiala; R W Honess; D C Heiner; J W Heine; J Murnane; R Wallace; L B Guze
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more
  51 in total

1.  An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.

Authors:  S Tugizov; E Maidji; J Xiao; L Pereira
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).

Authors:  M Mach; B Kropff; P Dal Monte; W Britt
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.

Authors:  B Wagner; B Kropff; H Kalbacher; W Britt; V A Sundqvist; L Ostberg; M Mach
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.

Authors:  M A Billstrom; W J Britt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Characterization of envelope proteins of alcelaphine herpesvirus 1.

Authors:  S W Adams; L M Hutt-Fletcher
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

8.  The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans.

Authors:  Y N Liu; A Klaus; B Kari; M F Stinski; J Eckhardt; R C Gehrz
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.

Authors:  Y Yamashita; K Shimokata; S Mizuno; T Daikoku; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.